Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Employee Health Plan topic
No spam. Unsubscribe anytime.
Charlotte County aims to curb rising drug costs by routing prescriptions through county clinic and new pharmacy
Summary
County officials told commissioners that a surge in prescription spending — largely driven by GLP‑1 weight‑loss drugs — pushed outpatient drug costs from about $6 million in 2022 to over $10 million in 2024. Staff said a new county pharmacy and clinic protocols could cut GLP‑1 costs by roughly 40% and asked for 90 days to report back on impacts and comparisons with neighboring counties.
Gordon Berger, director of Budget Administrative Services, told the Charlotte County Board of County Commissioners on June 19 that prescription drugs are the primary driver of a recent spike in the county’s medical costs and that much of the rise is concentrated in GLP‑1 class medications.
Berger said the county’s gross prescription costs climbed from about $6,000,000 in 2022 to more than $10,000,000 in 2024. "Three quarters of it" of the recent increase, he said, is attributable to GLP‑1 drugs, and he described the county’s new employee pharmacy as a tool to control price and prescribing behavior.
The county has been operating a physician‑based pharmacy on a soft opening since early spring and has expanded its formulary. Berger said routing prescriptions through the county pharmacy would allow clinical protocols and internal controls to be applied. "Now that we have our own pharmacy, we can control how those drugs are sent to the pharmacy," Berger said, adding that filling GLP‑1 prescriptions through the county pharmacy could reduce the county’s purchase price by about 40%.
Commissioners pressed for more detail: Chair and others asked whether employees would be required to use the county clinic and pharmacy and whether the county can lawfully carve out specific drugs or enrollees. Berger said the county follows Cigna’s coverage protocols for benefit administration and that legal constraints limit the county’s ability to single out drugs or groups for different co‑pays, but that channeling prescriptions through the clinic would let the county ensure clinical protocols are followed.
Commissioner Constance urged careful stewardship and behavior‑change programs to accompany medication use, saying the county should require participation in lifestyle and monitoring programs when prescribing expensive drugs. "We better have a very specific behavior modification program as part of this whole thing," Constance said.
Berger outlined immediate next steps: staff will pursue the clinic‑first routing with Cigna, continue to expand the county pharmacy’s formulary and monitor monthly prescription migrations, and will return to the board in 90 days with updated utilization and cost data, including comparisons to neighboring counties. He also told commissioners staff had gone to bid and looked at other administrators and would present a renewal in July; if Cigna cannot reach agreement to restore key network access (Sarasota Memorial was cited as out of network), the county has a contingency to present an alternative carrier in July.
The board did not take formal action but directed staff to report back with more detailed Rx trend data, migration metrics for prescriptions into the county pharmacy, and comparative GLP‑1 spending figures for nearby counties.
